The main department of described Corporate Investor is located in the Hong Kong. The venture was found in Asia in Hong Kong.
Among the most popular portfolio startups of the fund, we may highlight Beijing LaKala Billing Services, JD Digits, Uber China. The fund has exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as B2C, Financial Services. For fund there is no match between the country of its foundation and the country of its the most frequent investments - China.
Besides them, we counted 1 critical employee of this fund in our database.
This China Taiping Insurance works on 9 percentage points less the average amount of lead investments comparing to the other organizations. The increased amount of exits for fund were in 2019. The usual things for fund are deals in the range of more than 100 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The typical startup value when the investment from China Taiping Insurance is more than 1 billion dollars. The real fund results show that this Corporate Investor is 0 percentage points less often commits exit comparing to other companies. The high activity for fund was in 2017.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the China Taiping Insurance, startups are often financed by Legend Capital, Hotung Venture Capital, Uber. The meaningful sponsors for the fund in investment in the same round are YF Capital (Yunfeng Capital), Vanke, Uber. In the next rounds fund is usually obtained by China Creation Ventures (CCV), COFCO, CICC.
Related Funds
Fund Name | Location |
Castik Capital Partners | Bayern, Germany, Munich |
Civic Innovation Lab | Cleveland, Ohio, United States |
Credit Agricole Entreprises | Centre, Centre-Loire Valley, France |
Dyson | Malmesbury, United Kingdom, Wiltshire |
Fund for Arkansas' Future | Arkansas, Little Rock, United States |
GVA Vestor.in | California, San Francisco, United States |
Hana Financial Investment | Seoul, Seoul-t'ukpyolsi, South Korea |
Infinity Group | China, Guangdong, Shenzhen |
Outerwall | Bellevue, United States, Washington |
Retty | Japan, Tokyo |
Shanghai Huaming Intelligent Terminal Equipment | China, Shanghai |
Shell Canada Ltd | Alberta, Calgary, Canada |
Shizen Energy | Japan, Tokyo |
Tech Equity Partners | Canada, Halifax, Nova Scotia |
Vestech International | - |
Virgin Green Fund | England, London, United Kingdom |
Wasp Ventures | Beijing, Beijing, China |
Zhejiang Lizi Venture Capital | China, Hangzhou, Zhejiang |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
METiS Pharmaceuticals | $100M | 22 Jun 2024 | Shangcheng District, Zhejiang, China | ||
Junjiu Electronics | $15M | 31 May 2023 | Shanghai, Shanghai, China | ||
Evaheart | $90M | 09 Mar 2023 | Houston, Texas, United States | ||
Doma Biopharmaceutical | $146M | 02 Jun 2022 | Kagoshima, Kagoshima Prefecture, Japan | ||
Yingsheng Biology | 29 Mar 2022 | Lixia District, Shandong, China | |||
Chexiang | $154M | 04 Dec 2017 | China, Shanghai | ||
Alisports | $185M | 11 Apr 2017 | China, Shanghai | ||
JD Finance | $1B | 16 Jan 2016 | Beijing, Beijing, China | ||
Uber China | $2B | 13 Jan 2016 | Beijing, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
METiS Pharmaceuticals | $100M | 22 Jun 2024 | Shangcheng District, Zhejiang, China | ||
Junjiu Electronics | $15M | 31 May 2023 | Shanghai, Shanghai, China | ||
Evaheart | $90M | 09 Mar 2023 | Houston, Texas, United States | ||
Doma Biopharmaceutical | $146M | 02 Jun 2022 | Kagoshima, Kagoshima Prefecture, Japan | ||
Yingsheng Biology | 29 Mar 2022 | Lixia District, Shandong, China | |||
Chexiang | $154M | 04 Dec 2017 | China, Shanghai | ||
Alisports | $185M | 11 Apr 2017 | China, Shanghai | ||
JD Finance | $1B | 16 Jan 2016 | Beijing, Beijing, China | ||
Uber China | $2B | 13 Jan 2016 | Beijing, Beijing, China |